Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy-Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients
Plinabulin (Plin), a Small Molecule with Anti-Cancer Activity and a Novel Mechanism of Action (MoA) in Docetaxel (Tax) Induced Neutropenia: Phase (φ) 2 Results from a Head-to-Head Comparison with Pegfilgrastim (Peg)
Plinabulin Ameliorates Chemotherapy-Induced Neutropenia: Mechanistic Insights
Guanine Nucleotide Exchange Factor-H1 Signaling is Critical for Induction of Anti-Tumor Immunity Induced by Microtubule-Depolymerizing Drugs
Plinabulin is a Small Molecule Clinical Stage Immune-Oncology Agent for NSCLC
© BeyondSpring Inc. All Rights Reserved.